These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 28426127)

  • 1. Postpartum Hypertension: Etiology, Diagnosis, and Management.
    Sharma KJ; Kilpatrick SJ
    Obstet Gynecol Surv; 2017 Apr; 72(4):248-252. PubMed ID: 28426127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral labetalol compared to oral nifedipine for postpartum hypertension: A randomized controlled trial.
    Sharma KJ; Greene N; Kilpatrick SJ
    Hypertens Pregnancy; 2017 Feb; 36(1):44-47. PubMed ID: 27786578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulse pressure as a predictor of response to treatment for severe hypertension in pregnancy.
    Mullan SJ; Vricella LK; Edwards AM; Powel JE; Ong SK; Li X; Tomlinson TM
    Am J Obstet Gynecol MFM; 2021 Nov; 3(6):100455. PubMed ID: 34375751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of factors associated with delayed treatment of obstetric hypertensive emergencies.
    Kantorowska A; Heiselman CJ; Halpern TA; Akerman MB; Elsayad A; Muscat JC; Sicuranza GB; Vintzileos AM; Heo HJ
    Am J Obstet Gynecol; 2020 Aug; 223(2):250.e1-250.e11. PubMed ID: 32067968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertensive crisis during pregnancy and postpartum period.
    Too GT; Hill JB
    Semin Perinatol; 2013 Aug; 37(4):280-7. PubMed ID: 23916027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Committee Opinion no. 514: emergent therapy for acute-onset, severe hypertension with preeclampsia or eclampsia.
    Obstet Gynecol; 2011 Dec; 118(6):1465-1468. PubMed ID: 22105295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review.
    Firoz T; Magee LA; MacDonell K; Payne BA; Gordon R; Vidler M; von Dadelszen P;
    BJOG; 2014 Sep; 121(10):1210-8; discussion 1220. PubMed ID: 24832366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: a randomized clinical trial.
    Vigil-De Gracia P; Ruiz E; López JC; de Jaramillo IA; Vega-Maleck JC; Pinzón J
    Hypertens Pregnancy; 2007; 26(2):163-71. PubMed ID: 17469006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of postpartum readmission after hypertensive disorder of pregnancy and variation by discharge antihypertensive medication prescription.
    Mitro SD; Hedderson M; Xu F; Forquer H; Baker JM; Kuzniewicz MW; Greenberg M
    Am J Obstet Gynecol; 2024 Oct; 231(4):456.e1-456.e13. PubMed ID: 38280432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with appropriate treatment of acute-onset severe obstetrical hypertension.
    Deshmukh US; Lundsberg LS; Culhane JF; Partridge C; Reddy UM; Merriam AA; Son M
    Am J Obstet Gynecol; 2021 Sep; 225(3):329.e1-329.e10. PubMed ID: 34023314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Committee Opinion No. 692 Summary: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period.
    Obstet Gynecol; 2017 Apr; 129(4):769-770. PubMed ID: 28333812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Committee Opinion No. 692: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period.
    Committee on Obstetric Practice
    Obstet Gynecol; 2017 Apr; 129(4):e90-e95. PubMed ID: 28333820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
    Easterling T; Mundle S; Bracken H; Parvekar S; Mool S; Magee LA; von Dadelszen P; Shochet T; Winikoff B
    Lancet; 2019 Sep; 394(10203):1011-1021. PubMed ID: 31378394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACOG Committee Opinion No. 767: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period.
    Obstet Gynecol; 2019 Feb; 133(2):e174-e180. PubMed ID: 30575639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of nifedipine, labetalol, and hydralazine as emergency antihypertension in severe preeclampsia: a randomized control trial.
    S D; Novri DA; Hamidy Y; Savira M
    F1000Res; 2022; 11():1287. PubMed ID: 37273965
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous labetalol versus oral nifedipine for acute hypertension in pregnancy: effects on cerebral perfusion pressure.
    Tolcher MC; Fox KA; Sangi-Haghpeykar H; Clark SL; Belfort MA
    Am J Obstet Gynecol; 2020 Sep; 223(3):441.e1-441.e8. PubMed ID: 32544404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACOG Committee Opinion No. 767 Summary: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period.
    Obstet Gynecol; 2019 Feb; 133(2):409-412. PubMed ID: 30681541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertensive Crisis in Pregnancy.
    Wautlet CK; Hoffman MC
    Obstet Gynecol Clin North Am; 2022 Sep; 49(3):501-519. PubMed ID: 36122982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral combined hydrochlorothiazide and lisinopril vs nifedipine for postpartum hypertension: a comparative-effectiveness pilot randomized controlled trial.
    Fishel Bartal M; Blackwell SC; Pedroza C; Lawal D; Amro F; Samuel J; Chauhan SP; Sibai BM
    Am J Obstet Gynecol; 2023 May; 228(5):571.e1-571.e10. PubMed ID: 36787814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiologic Treatment of Severe Hypertension in Pregnancy and Postpartum.
    Davis AM; Blanchard CT; Subramaniam A; Sinkey RG; Tita AT; Battarbee AN
    Obstet Gynecol; 2024 Feb; 143(2):277-280. PubMed ID: 38033320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.